Evidence map›Paper›PMID 33469121›Full record

ArticleScientific reports2021

Washing with alkaline solutions in protein A purification improves physicochemical properties of monoclonal antibodies.

Yuichi Imura, Toshiaki Tagawa, Yuya Miyamoto, Satoshi Nonoyama, Hiroshi Sumichika, Yasuhiro Fujino, Masaya Yamanouchi, Hideo Miki

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cancer therapy via neoepitope-specific monoclonal antibody cocktails.Cancer immunology, immunotherapy : CII · 2025
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yuichi ImuraSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan. yimura@trlusa.com.
Toshiaki Tagawa *Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Yuya Miyamoto *Sohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Japan.
Satoshi NonoyamaSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Hiroshi SumichikaSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Yasuhiro FujinoSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Masaya YamanouchiSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan.
Hideo MikiSohyaku. Innovative Research Department, Mitsubishi Tanabe Pharma Corporation, Fujisawa, Japan.
Mitsubishi Group (Japan) · JPMitsubishi Tanabe Pharma CorporationTanabe Research Laboratories · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein A affinity chromatography has been widely used for both laboratory scale purification and commercial manufacturing of monoclonal antibodies and Fc-fusion proteins. Protein A purification is specific and efficient. However, there still remain several issues to be addressed, such as incomplete clearance of impurities including host cell proteins, DNA, aggregates, etc. In addition, the effects of wash buffers in protein A purification on the physicochemical characteristics of antibodies have yet to be fully understood. Here we found a new purification protocol for monoclonal antibodies that can improve physicochemical properties of monoclonal antibodies simply by inserting an additional wash step with a basic buffer after the capture step to the conventional protein A purification. The effects of the alkaline wash on monoclonal antibodies were investigated in terms of physicochemical characteristics, yields, and impurity clearance. The simple insertion of an alkaline wash step resulted in protection of antibodies from irreversible aggregation, reduction in free thiols and impurities, an improvement in colloidal and storage stability, and enhanced yields. This new procedure is widely applicable to protein A affinity chromatography of monoclonal antibodies.

Indexed as

AlkaliesAntibodies, MonoclonalChromatography, AffinityChromatography, GelElectrophoresis, Polyacrylamide GelSolutionsStaphylococcal Protein AAlkaliesAntibodies, MonoclonalSolutionsStaphylococcal Protein A

Identifiers

PMID33469121
PMCPMC7815873
OpenAlexW3122380155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.